Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Oramed Initiates Phase 3 Trial of Oral Insulin

americanpharmaceuticalreviewDecember 11, 2020

Tag: Diabetes , Oramed , T2D , oral insulin , ORMD-0801

PharmaSources Customer Service